Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$245M |
| 2 |
KeyCorp
KEY
|
+$199M |
| 3 |
RTX Corp
RTX
|
+$183M |
| 4 |
EMC
EMC CORPORATION
EMC
|
+$170M |
| 5 |
Ralph Lauren
RL
|
+$167M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$245M |
| 2 |
US Bancorp
USB
|
+$216M |
| 3 |
Apple
AAPL
|
+$207M |
| 4 |
Visa
V
|
+$188M |
| 5 |
Bank of America
BAC
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 44.36% |
| 2 | Financials | 9.66% |
| 3 | Consumer Discretionary | 8.08% |
| 4 | Energy | 7.72% |
| 5 | Technology | 6.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2301
CALL
ATI
ATI
$26.2B
| $2M | ﹤0.01% |
65,400
-3,200
| -5% | -$89.6K |
2013 Q2
1 quarter
|
|
|
UAM
2302
DELISTED
Universal American Corp
UAM
| $2M | ﹤0.01% |
261,899
-307,741
| -54% | -$2.7M |
2013 Q2
1 quarter
|
|
2303
National Bank Holdings
NBHC
$1.69B
| $1.99M | ﹤0.01% |
96,968
+75,466
| +351% | +$1.51M |
2013 Q2
1 quarter
|
|
|
CNQR
2304
CALL
DELISTED
CONCUR TECHNOLOGIES INC
CNQR
| $1.99M | ﹤0.01% |
18,000
-7,900
| -31% | -$769K |
2013 Q2
1 quarter
|
|
|
BRY
2305
PUT
DELISTED
BERRY PETROLEUM CO CL A
BRY
| $1.98M | ﹤0.01% |
46,000
+10,200
| +28% | +$425K |
2013 Q2
1 quarter
|
|
2306
PUT
Hovnanian Enterprises
HOV
$693M
| $1.98M | ﹤0.01% |
15,164
-1,012
| -6% | -$135K |
2013 Q2
1 quarter
|
|
2307
Medtronic
MDT
$110B
| $1.98M | ﹤0.01% |
37,200
-65,806
| -64% | -$3.54M |
2013 Q2
1 quarter
|
|
|
ARNA
2308
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $1.98M | ﹤0.01% |
37,578
-57,073
| -60% | -$3.83M |
2013 Q2
1 quarter
|
|
|
ARUN
2309
PUT
DELISTED
ARUBA NETWORKS, INC.
ARUN
| $1.98M | ﹤0.01% |
118,900
-97,900
| -45% | -$1.71M |
2013 Q2
1 quarter
|
|
2310
First Financial Bancorp
FFBC
$3.35B
| $1.98M | ﹤0.01% |
130,288
+21,105
| +19% | +$332K |
2013 Q2
1 quarter
|
|
|
FNSR
2311
CALL
DELISTED
Finisar Corp
FNSR
| $1.98M | ﹤0.01% |
87,300
+13,200
| +18% | +$272K |
2013 Q2
1 quarter
|
|
|
BCR
2312
DELISTED
CR Bard Inc.
BCR
| $1.98M | ﹤0.01% |
17,143
-39,590
| -70% | -$4.54M |
2013 Q2
1 quarter
|
|
|
VAR
2313
CALL
DELISTED
Varian Medical Systems, Inc.
VAR
| $1.97M | ﹤0.01% |
30,106
+13,913
| +86% | +$881K |
2013 Q2
1 quarter
|
|
2314
Federated Hermes
FHI
$4.19B
| $1.97M | ﹤0.01% |
+72,517
| New | +$2.06M |
2013 Q3
0 quarters
|
|
2315
PUT
PACCAR
PCAR
$57.7B
| $1.97M | ﹤0.01% |
53,100
-20,400
| -28% | -$759K |
2013 Q2
1 quarter
|
|
|
SRCL
2316
CALL
DELISTED
Stericycle Inc
SRCL
| $1.96M | ﹤0.01% |
17,000
+8,200
| +93% | +$946K |
2013 Q2
1 quarter
|
|
2317
PUT
EQT Corp
EQT
$31.4B
| $1.96M | ﹤0.01% |
40,598
+9,920
| +32% | +$460K |
2013 Q2
1 quarter
|
|
|
2318
PUT
ATI
ATI
$26.2B
| $1.96M | ﹤0.01% |
64,200
+15,000
| +30% | +$420K |
2013 Q2
1 quarter
|
|
|
NPSP
2319
CALL
DELISTED
NPS PHARMACEUTICALS INC
NPSP
| $1.96M | ﹤0.01% |
61,500
+4,600
| +8% | +$106K |
2013 Q2
1 quarter
|
|
2320
Fluor
FLR
$6.67B
| $1.95M | ﹤0.01% |
27,473
+12,398
| +82% | +$804K |
2013 Q2
1 quarter
|
|
|
CB
2321
DELISTED
CHUBB CORPORATION
CB
| $1.95M | ﹤0.01% |
21,840
-6,223
| -22% | -$538K |
2013 Q2
1 quarter
|
|
2322
CALL
PRA Group
PRAA
$710M
| $1.95M | ﹤0.01% |
32,500
+5,200
| +19% | +$279K |
2013 Q2
1 quarter
|
|
|
WCC
2323
WESCO International
WCC
$18.6B
| $1.94M | ﹤0.01% |
25,363
-47,045
| -65% | -$3.49M |
2013 Q2
1 quarter
|
|
|
XEC
2324
CALL
DELISTED
CIMAREX ENERGY CO
XEC
| $1.94M | ﹤0.01% |
20,100
-2,000
| -9% | -$162K |
2013 Q2
1 quarter
|
|
2325
Papa John's
PZZA
$640M
| $1.94M | ﹤0.01% |
55,444
-70,064
| -56% | -$2.42M |
2013 Q2
1 quarter
|
|
Similar funds
Citadel Advisors's Q3 2013 Portfolio in Review
As of Q3 2013, Citadel Advisors held 7,215 positions worth $65.7B, up 13% from $58.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Citadel Advisors withdrew a net $4.68B in Q3 2013, closing 505 positions and reducing 3,074 holdings. Its most notable exit was NEWS CORPORATION CL-A, an estimated $166M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 44% of assets, up from 41% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Citadel Advisors opened a new position in ELAN CORP ADS(RP1 ORD4IRISH PN worth $100M.
- Citadel Advisors's largest Q3 2013 buy was ELAN CORP ADS(RP1 ORD4IRISH PN: 6,448,014 shares worth $100M.
- Citadel Advisors added most to Philip Morris in Q3 2013, an estimated $245M increase.
- Citadel Advisors's biggest Q3 2013 reduction was Pfizer, cutting an estimated $245M.
- Citadel Advisors fully exited NEWS CORPORATION CL-A in Q3 2013, selling an estimated $166M.
- Citadel Advisors's ten largest holdings make up 12% of its $65.7B portfolio in Q3 2013.
- Citadel Advisors opened 734 new positions and closed 505 in Q3 2013.
- Citadel Advisors's portfolio value rose 13% quarter-over-quarter to $65.7B.
Based on Citadel Advisors's 13F filing for Q3 2013, filed 14 Nov 2013.